Background It is unclear whether the systemic inflammation response index (SIRI) can
predict the prognosis of patients with hepatocellular carcinoma (HCC). Consequently, the …

The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in
some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in …

Background: There is a growing literature on the significance of systemic immune-
inflammation index in hepatocellular carcinoma. However, the results were inconsistent due …

摘要 Objective: A meta-analysis was conducted to estimate the prognostic value of systemic
immune-inflammation index (SII) for the patients with HCC. Methods: The databases …

Aim: To explore the prognostic value of the systemic inflammatory response index (SIRI) and
peripheral blood T-cell subsets in patients with hepatocellular carcinoma (HCC) and the …

This study aimed to investigate the clinical significance of systemic inflammation markers
(SIMs)—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) …

Purpose: We developed a novel systemic immune-inflammation index (SII) based on
lymphocyte, neutrophil, and platelet counts and explored its prognostic value in …

Background Mounting evidence has shown that systemic inflammation response index
(SIRI), a novel prognostic biomarker based on peripheral lymphocyte, neutrophil and …

Purpose To investigate the value of preoperative systemic inflammation response (SIRS)
score in predicting the prognosis of hepatocellular carcinoma (HCC) after hepatectomy …

Background: There is growing evidence that the systemic immune-inflammation index (SII),
a novel prognostic biomarker based on peripheral lymphocyte, neutrophil, and platelet …